Expression of EGFR under tumor hypoxia: Identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 3, 2012, Pages 807-814

  Hoogsteen, Ilse J ^a   Marres, Henri A M ^a   Van Den Hoogen, Franciscus J A ^a   Rijken, Paul F J W ^a   Lok, Jasper ^a   Bussink, Johan ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colocalization; EGFR; Head and neck carcinomas; Subpopulation; Tumor hypoxia

Indexed keywords

COLOCALIZATION; EGFR; HEAD AND NECK; SUBPOPULATION; TUMOR HYPOXIA;

BIOPSY; CELLS; CYTOLOGY;

TUMORS;

EPIDERMAL GROWTH FACTOR RECEPTOR; PIMONIDAZOLE;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL SUBPOPULATION; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS FREE SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR BIOPSY; TUMOR HYPOXIA;

CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL SURVIVAL; DISEASE-FREE SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; NITROIMIDAZOLES; PROGNOSIS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866739275     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.002     Document Type: Article

References (18)

1. S. Marur, and A.A. Forastiere Head and neck cancer: Changing epidemiology, diagnosis, and treatment Mayo Clin Proc 83 2008 489 501
2. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
3. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: The complexity of targeted inhibitors Nat Rev Cancer 5 2005 341 354
4. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signaling network Nat Rev Mol Cell Biol 2 2001 127 137
5. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356
6. P. Vaupel, and A. Mayer Hypoxia in cancer: Significance and impact on clinical outcome Cancer Metastasis Rev 26 2 2007 225 239
7. J.H.A.M. Kaanders, K.I.E.M. Wijffels, and H.A.M. Marres Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
8. J.H.A.M. Kaanders, J. Bussink, and A.J. van der Kogel Clinical studies of hypoxia modification in radiotherapy Semin Radiat Oncol 14 2004 233 240
9. J.H.A.M. Kaanders, J. Bussink, and A.J. van der Kogel ARCON: A novel biology-based approach in radiotherapy Lancet Oncol 3 2002 728 737
10. S.M. Bentzen, B.M. Atasoy, and F.M. Daley Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated therapy in a randomized controlled trial J Clin Oncol 24 2005 5560 5567
11. D.A. Wing, G.D. Talley, and T.G. Storch Oxygen concentration regulates EGF-induced proliferation and EGF-receptor down regulation Biochem Biophys Res Commun 153 1988 952 958
12. A. Franovic, L. Gunaratnam, and K. Smith Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer Proc Natl Acad Sci U S A 104 2007 13092 13097
13. H. Zhong, K. Chiles, and D. Feldser Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phophatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics Cancer Res 60 2000 1541 1545
14. M. Krause, G. Ostermann, and C. Petersen Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation Radiother Oncol 76 2005 162 167
15. N. Qayum, R.J. Muschel, and J.H. Im Tumor vascular changes mediated by inhibition of oncogenic signaling Cancer Res 69 2009 6347 6354
16. M.P. Morelli, T. Cascone, and T. Troiani Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases J Cell Physiol 208 2006 344 353
17. J.G. Eriksen, T. Steiniche, and J. Overgaard The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma Acta Oncol 44 2005 50 58
18. R.K. Schmidt-Ullrich, J.N. Contessa, and P. Dent Molecular mechanisms of radiation-induced accelerated repopulation Radiat Oncol Invest 7 1999 321 330